Gene and Cell Therapies Hold Potential—but How Can Payers Manage Their Costs?

American Journal of Managed Care (AJMC): Presenters at the Academy of Managed Care Pharmacy (AMCP) 2024 annual meeting discussed the current promise and future potential of gene and cell therapies, as well as payer management strategies for these costly treatments

April 19, 2024

Related news

In the news

May 8, 2024

Meet the Board: Navigating the Evolving Landscape of Healthcare Coverage and Pharmacy Benefits with Marci Chodroff of Magellan, Prime Therapeutics

Managed Healthcare Executive: This month's episode of the Meet the Board podcast features a new member of our editorial advisory board, Marci J. Chodroff, MD, FACP, vice president of Medical Affairs at Magellan Rx Management, a Prime Therapeutics company

In the news

April 24, 2024

AMCP 2024: Key Takeaways From Leading Speakers

American Journal of Managed Care (AJMC): Session speakers at the Academy of Managed Care Pharmacy (AMCP) 2024 annual conference share their favorite parts of the event and the key takeaways they will leave the conference with